Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Leonidas JC, Guelfguat M, Valderrama E. Langerhans’cell histiocytosis. Lancet 2003;361:1293–1295
Schmitz L, Favara BE. Nosology and pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:221–246
Nezelof C, Basset F, Rousseau MF. Histiocytosis X: Histogenetic arguments for a Langerhans’ cell origin. Biomedicine 1973;18:565–571
Chu T, DiAngio GJ, Favara B, Ladisch S, the Writing group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet 1987;1:208–209
Nicholson HS, Egeler RM. The epidemiology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:379–384
Arico M, Egeler RM. Clinical aspects of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:247–258
Grois NG, Favara BE, Mostbeck GH, Prayer D. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:287–305
Hund E, Steiner H-H, Jansen O, Sieverts H, Sohl G, Essig M. Treatment of cerebral Langerhans cell histiocytosis. J Neurol Sci 1999;171:145–152
Grois N, Prayer D, Prosch H, Minkow M, Potschger U, Gadner H. Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis. Pediatr Blood Cancer 2004;43: 59–65
Fadeel B, Henter J-I. Langerhans cell histiocytosis: neoplasia or unbridled inflammation? Trends Immunol 2003;24: 409–411
Prayer D, Grois N, Prosch H, Gadner H, Barkovich AJ. MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis. AJNR 2004;25:880–891
Lahey, ME. Histiocytosis X — an analysis of prognostic factors. J Pediatr 1975;87:184–189
Egeler RM, D’Angio GJ. Langerhans cell histiocytosis. J Pediatr 1995;127:1–11
Arceci RJ, Brenner MK, Pritchard J. Controversies and new approaches to treatment of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:339–357
Gadner H, Grois N, Arico M, Broadbent V, Ceci A, Jakobson A, et al. A randomized trial of treatment for multisystem Langerhans’ cell histiocytosis. J Pediatr 1994;138:728–734
The French Langerhans’ Cell Histiocytosis Study Group. A multicentre retrospective survey of Langerhans cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child 1996;75:17–24
Goh NS, Mcdonald CF, Macgregor DP, Pretto JJ, Brodie GN. Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine: Respirology 2003;8:91–94
Haupt R, Nanduri V, Grazia Calevo M, Bernstrand C, Braier JL, Broadbent V, et al. Permanent consequences in Langerhans cell histiocytosis patients: A pilot study from the 554 Clare Gallagher, Walter J. Hader Histiocyte Society Late-Effects Study Group. Pediatr Blood Cancer 2004;42:436–444
Egeler RM, Annels NE, Hogendoorn PCW. Langerhans cell histiocytosis: A pathologic combination of oncogenesis and immune dysregulation. Pediatr Blood Cancer 2004;42:401–403
Henter J-I, Karlen J, Calming U, Bernstrand C, Andersson U, Fadeel B. Successful treatment of Langerhans’ cell histiocytosis with Etanercept. N Engl J Med 2001;345:1577–78
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gallagher, C., Hader, W.J. (2006). Langerhans Cell Histiocytosis. In: Tonn, JC., Grossman, S.A., Rutka, J.T., Westphal, M. (eds) Neuro-Oncology of CNS Tumors. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31260-9_45
Download citation
DOI: https://doi.org/10.1007/3-540-31260-9_45
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-25833-9
Online ISBN: 978-3-540-31260-4
eBook Packages: MedicineMedicine (R0)